Stephen Gregory Delgado is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of neuroscience through his innovative work on tetrodotoxin-resistant sodium channels. With a total of 5 patents to his name, Delgado's inventions have the potential to impact therapeutic approaches for disorders of the peripheral nervous system.

Latest Patents

Delgado's latest patents include a method of modulating tetrodotoxin-resistant sodium channels. This invention relates to a voltage-gated sodium channel found in peripheral nerve tissue that is resistant to tetrodotoxin. One aspect of this invention involves purified and isolated DNA encoding this sodium channel. Additionally, it encompasses the recombinant protein expressed by this DNA, expression vectors that include the DNA sequence, and host cells transformed with these expression vectors. The invention also highlights the use of this voltage-gated, tetrodotoxin-resistant sodium channel as a therapeutic target for compounds aimed at treating disorders of the peripheral nervous system.

Career Highlights

Throughout his career, Stephen Gregory Delgado has worked with various companies, including Syntex (U.S.A.) Inc. His experience in the industry has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Delgado has collaborated with notable coworkers such as Linda Marie Fish and Lakshmi Sangameswaran. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Stephen Gregory Delgado's work exemplifies the intersection of innovation and medical science. His contributions to the understanding and application of tetrodotoxin-resistant sodium channels hold promise for future therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com